Abstract
Oximes are acetylcholinesterase reactivators of use in poisoning with organophosphorus inhibitors of cholinesterase (OPIChE: (organophosphates and organophosphonates). Pralidoxime (1) and obidoxime (2) are clinically used as an adjunct to atropine in such exposure. Clinical experience with oximes is however disappointing. The paper reviews the available data concerning the ability of established and new oximes to reactivate cholinesterases inhibited by two differently substituted prototypical organophosphates: ethyl-paraoxon (3) and methyl-paraoxon (4). Reactivation ability is quantified in vitro via the IC50 shift curve. The slope of the shift curve (tg α) is used to quantify the magnitude of the protective effect (nM IC50 increase per microM reactivator). The ranking of reactivator potencies of the examined oximes determined with 4 as an inhibitor is essentially the same as the ranking obtained using 3 as an inhibitor. In the in vitro model used, the presence of ethyl vs. methyl substituents does not seem to significantly alter the in vitro ability of the examined oximes to reactivate the esterase. In vitro derived results were subsequently validated in vivo in rats using 3 and 4 as cholinesterase inhibitors and various oximes as reactivator. Mortality data were compared and hazards ratios calculated using Cox proportional hazards model. Overall the ability of the in vitro testing (tg α determinations) to predict in vivo performance of the oximes is limited.
Current Organic Chemistry
Title: Comparison of the Ability of Pyridinium Aldoximes to Reactivate Human RBC Cholinesterases Inhibited by Ethyl- and Methyl-Paraoxon
Volume: 11 Issue: 18
Author(s): Georg A. Petroianu and Huba Kalasz
Affiliation:
Abstract: Oximes are acetylcholinesterase reactivators of use in poisoning with organophosphorus inhibitors of cholinesterase (OPIChE: (organophosphates and organophosphonates). Pralidoxime (1) and obidoxime (2) are clinically used as an adjunct to atropine in such exposure. Clinical experience with oximes is however disappointing. The paper reviews the available data concerning the ability of established and new oximes to reactivate cholinesterases inhibited by two differently substituted prototypical organophosphates: ethyl-paraoxon (3) and methyl-paraoxon (4). Reactivation ability is quantified in vitro via the IC50 shift curve. The slope of the shift curve (tg α) is used to quantify the magnitude of the protective effect (nM IC50 increase per microM reactivator). The ranking of reactivator potencies of the examined oximes determined with 4 as an inhibitor is essentially the same as the ranking obtained using 3 as an inhibitor. In the in vitro model used, the presence of ethyl vs. methyl substituents does not seem to significantly alter the in vitro ability of the examined oximes to reactivate the esterase. In vitro derived results were subsequently validated in vivo in rats using 3 and 4 as cholinesterase inhibitors and various oximes as reactivator. Mortality data were compared and hazards ratios calculated using Cox proportional hazards model. Overall the ability of the in vitro testing (tg α determinations) to predict in vivo performance of the oximes is limited.
Export Options
About this article
Cite this article as:
Petroianu A. Georg and Kalasz Huba, Comparison of the Ability of Pyridinium Aldoximes to Reactivate Human RBC Cholinesterases Inhibited by Ethyl- and Methyl-Paraoxon, Current Organic Chemistry 2007; 11 (18) . https://dx.doi.org/10.2174/138527207783221183
DOI https://dx.doi.org/10.2174/138527207783221183 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model
Current Alzheimer Research Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase
Current Computer-Aided Drug Design Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands
Mini-Reviews in Medicinal Chemistry Genomic and Proteomic Approaches Towards an Understanding of Sleep
CNS & Neurological Disorders - Drug Targets Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Letters in Drug Design & Discovery Sulfur Containing Acridine Derivatives in Preclinical Studies with Cancer Cell Lines
Current Medicinal Chemistry Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury
Current Neurovascular Research Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE
Current HIV Research Role of Stereotactic Radiosurgery in the Management of Brain and Spine Metastases
Current Cancer Therapy Reviews A Short Historical Survey of Developments in Amyloid Research
Protein & Peptide Letters The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review
Current Drug Abuse Reviews Disequilibrium and Risk of Falling in the Elderly is a Priority for Health Services
Reviews on Recent Clinical Trials Investigating Mitochondrial Dysfunction to Increase Drug Safety in the Pharmaceutical Industry
Current Drug Targets Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Fish Oil Prevents Oxidative Stress and Exerts Sustained Antiamnesic Effect After Global Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues
Current Drug Safety MicroRNA Expression Levels in Patients with Hashimoto Thyroiditis: A Single Centre Study
Endocrine, Metabolic & Immune Disorders - Drug Targets GABAB Receptors-Associated Proteins: Potential Drug Targets in Neurological Disorders?
Current Drug Targets Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions
Medicinal Chemistry